ZYXI - יחס חוב להיוון בספרים Zynex Medical

Zynex, Inc. relies on robust liquidity and a steady stream of funds from medical centers. High margins are driven by the multi-year procurement of consumables and electrodes by patients. Fluctuations in the debt-to-equity ratio clearly demonstrate financial stability, where 0.00 becomes the new value of the indicator. The final outcome depends on government policy regarding non-drug pain management and the recognition of electrotherapy methods by physicians.

This indicator measures the degree of the business's reliance on borrowed funds relative to its equity. The calculation is based on a dynamic comparison of all liabilities against the book value of assets. By analyzing the ratio of debt obligations to book capital, an investor assesses the financial stability of Zynex, Inc. (ZYXI). A low debt load confirms the company's reliability, allowing it to effectively leverage its leadership in electrotherapy for expansion without the risk of excessive credit dependence.